May Griffith is a Professor at the Department of Ophthalmology, University of Montreal, Canada, working at the Maisonneuve-Rosemont Hospital Research Centre. She holds the Canada Research Chair in Biomaterials and Stem Cells in Ophthalmology and Caroline Durand Foundation Research Chair in Cellular Therapy of the Eye. She is currently the Director of the Cornea and Anterior Segment Axis of the Quebec Vision Health Research Network. MG is known for her pioneering work in translational regenerative medicine and in situ tissue regeneration. MG, Per Fagerholm and their team developed the world’s first cell-free biosynthetic corneal implants that promoted human corneal tissue and nerve regeneration in a human clinical trial in Sweden. Since then, she and Virender Sangwan completed a second clinical trial with biosynthetic corneal implants containing an inflammation-suppressing polymer network on high-risk patients. Most recently, MG and her team developed an injectable LiQD Cornea for repairing corneal perforations in place of toxic cyanoacrylate glue. LiQD Cornea is applied as a liquid, but quickly adheres and gels within corneal tissue defects. Then its similarity at a molecular level to a natural tissue framework promotes tissue regeneration, treating corneal perforations effectively without transplantation.MG continues her bench-to-bedside work in cornea regeneration, developing biomimetic biomaterials for regenerative medicine to meet unmet medical needs.